Jci_page_head_homepage_01 Jci_page_head_homepage_02
Gerald I. Shulman
Published in Volume 106, Issue 2
J Clin Invest. 2000; 106(2):171–176 doi:10.1172/JCI10583
Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

Potential rate-controlling steps responsible for reduced insulin-stimulated muscle glycogen synthesis in patients with type 2 diabetes mellitus. UDP, uridine diphosphate.